Upcoming IPOs
All IPOs

Gaudium IVF & Women's Health Ltd IPO Review

Listed

Healthcare Service Provider · Listed on BSE , NSE · 20 Feb 2026 - 24 Feb 2026

Jagat JoshiJagat Joshi
November 2, 2026
Issue Size
165.00 Cr
Price Band
₹75.00 - ₹79.00
Lot Size
189 Shares
Min Investment
₹14,931
GMP
₹-4
Subscription
7.27x
₹840.17 Cr
IPO Timeline
IPO OpensDONE
20 Feb 2026
IPO ClosesDONE
24 Feb 2026
Basis of AllotmentDONE
25 Feb 2026
RefundsDONE
26 Feb 2026
Demat CreditDONE
26 Feb 2026
ListingDONE
27 Feb 2026

About Gaudium IVF & Women's Health Ltd IPO

Gaudium IVF IPO open date is February 20, 2026 and the IPO will close on February 24, 2026. Gaudium IVF IPO is a Book build Issue. The company to raise around ₹165 crores via IPO that comprises fresh issue of ₹90 crores and offer for sale up to 94,93,700 equity shares with face value of ₹5 each.

Gaudium IVF IPO price band is ₹75 to ₹79 per share. The retail quota is 35%, QIB is 50%, and HNI is 15%. Gaudium IVF IPO to list on BSE NSE on February 27, 2026. The allotment of Gaudium IVF IPO date is February 25, 2026.

The company reported revenue of ₹70.96 crores in 2025 against ₹48.15 crores in 2024. The company reported profit of ₹19.13 crores in 2025 against profit of ₹10.32 crores in 2024. As per the financials the IPO investors should apply the IPO for a long term.

Advertisement
Back to IPO Details

IPO Recommendations

Consensus review from market research firms & brokerage analysts

2
analysts
1
Apply
1
May Apply
0
Neutral
0
Avoid

Gaudium IVF & Women's Health Ltd Review

ReviewerReviewDocument / Link
S
Swastika Investmart Ltd
ApplyPDF Report
D
Dilip Davda
May ApplyView Review

User Reviews

Community Sentiment
Votes submitted by verified retail investors
0
votes
0
Apply
0
May Apply
0
Neutral
0
Avoid

Add Your Review

What is your recommendation for this IPO?

Loading options…

How would you rate this IPO (1 to 5)?

3
Disclaimer:

The IPO reviews, and recommendations published on this page are provided by respective authors, brokers, analysts, and contributors. These views do not represent the views of IPO Watch, its management, or its staff.

IPO Watch does not guarantee about the information or recommendations provided by third-party contributors. Use this content for informational and educational purposes only.

Investors are advised to do their own research, check offer documents, and consult a qualified financial adviser before making investment decisions.

IPO Watch reserves the right to review, modify, or remove any content that does not meet the editorial guidelines.

Advertisement

Frequently Asked Questions (FAQ)

Comments0

Join the discussion

Please sign in to leave a comment or reply.

Sorted by